Pay in 4 interest-free payments of $7.16 Learn more
Ships within 48 hours · Estimated delivery Nov 9 - Nov 14
Caruso, M.I
Gadelha, M
10.1038/onc.2017.38 Summary Keywords alcohol-associated liver disease (ALD), glucagon-like peptide 1 receptor agonists (GLP-1 RAs), metabolic dysfunction and alcohol-associated liver disease (MetALD), metabolic dysfunction-associated steatotic liver disease (MASLD), steatotic liver disease (SLD) Citation Mahalingam S, Kharbanda KK, Casey CA and Rasineni K (2026) Beyond diabetes and obesity: GLP-1 receptor agonists as multifunctional therapeutics across the steatotic liver disease spectrum
Always review the full safety information that comes with your prescription and discuss any concerns, current medications, or health conditions with your provider before starting treatment
US$ 24.25
US$ 28.14
US$ 29.21
US$ 25.18
US$ 25.99
US$ 27.57
US$ 27.33
US$ 23.88
US$ 29.26
US$ 23.17
